Next Article in Journal
Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets
Next Article in Special Issue
NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma
Previous Article in Journal
Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
Previous Article in Special Issue
Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications
Article Menu
Issue 2 (February) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2018, 19(2), 595; https://doi.org/10.3390/ijms19020595

Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma

1
Research Unit, Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas”, Calzada de Tlalpan 4502, Colonia Sección XVI, 14080 Mexico City, Mexico
2
Unidad de Investigación en Biomedicina (UBIMED), Cancer Epigenomics and Lung Disease Laboratory 12, Facultad de Estudios Superiores (FES)-Iztacala, Universidad Nacional Autónoma de México, Avenida de los Barrios #1 Colonia los Reyes Iztacala, 54090 Mexico City, Mexico
*
Author to whom correspondence should be addressed.
Received: 29 December 2017 / Revised: 26 January 2018 / Accepted: 30 January 2018 / Published: 17 February 2018
(This article belongs to the Special Issue Mesothelioma Heterogeneity: Potential Mechanisms)
Full-Text   |   PDF [1035 KB, uploaded 17 February 2018]   |  

Abstract

Malignant pleural mesothelioma (MPM) is a rare but aggressive tumor that originates in the pleura, is diagnosed in advanced stages and has a poor prognosis. Accurate diagnosis of MPM is often difficult and complex, and the gold standard diagnosis test is based on qualitative analysis of markers in pleural tissue by immunohistochemical staining. Therefore, it is necessary to develop quantitative and non-subjective alternative diagnostic tools. MicroRNAs are non-coding RNAs that regulate essential cellular mechanisms at the post-transcriptional level. Recent evidence indicates that miRNA expression in tissue and body fluids is aberrant in various tumors, revealing miRNAs as promising diagnostic biomarkers. This review summarizes evidence regarding secreted and tissue miRNAs as biomarkers of MPM and the biological characteristics associated with their potential diagnostic value. In addition to studies regarding miRNAs with potential diagnostic value for MPM, studies that aimed to identify the miRNAs involved in molecular mechanisms associated with MPM development are described with an emphasis on relevant aspects of the experimental designs that may influence the accuracy, consistency and real diagnostic value of currently reported data. View Full-Text
Keywords: malignant pleural mesothelioma; microRNAs; diagnosis biomarkers malignant pleural mesothelioma; microRNAs; diagnosis biomarkers
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Martínez-Rivera, V.; Negrete-García, M.C.; Ávila-Moreno, F.; Ortiz-Quintero, B. Secreted and Tissue miRNAs as Diagnosis Biomarkers of Malignant Pleural Mesothelioma. Int. J. Mol. Sci. 2018, 19, 595.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top